- Home
- NMRA vs INFU Comparison
NMRA vs INFU Comparison
Compare NMRA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- INFU
- Stock Information
- Founded
- NMRA 2019
- INFU 2005
- Country
- NMRA United States
- INFU United States
- Employees
- NMRA N/A
- INFU N/A
- Industry
- NMRA
- INFU Medical/Dental Instruments
- Sector
- NMRA
- INFU Health Care
- Exchange
- NMRA Nasdaq
- INFU Nasdaq
- Market Cap
- NMRA 112.8M
- INFU 104.4M
- IPO Year
- NMRA 2023
- INFU N/A
- Fundamental
- Price
- NMRA $0.73
- INFU $5.69
- Analyst Decision
- NMRA Buy
- INFU
- Analyst Count
- NMRA 8
- INFU 0
- Target Price
- NMRA $9.29
- INFU N/A
- AVG Volume (30 Days)
- NMRA 846.2K
- INFU 176.5K
- Earning Date
- NMRA 05-12-2025
- INFU 05-08-2025
- Dividend Yield
- NMRA N/A
- INFU N/A
- EPS Growth
- NMRA N/A
- INFU 3654.89
- EPS
- NMRA N/A
- INFU 0.15
- Revenue
- NMRA N/A
- INFU $137,582,000.00
- Revenue This Year
- NMRA N/A
- INFU $11.08
- Revenue Next Year
- NMRA N/A
- INFU $8.02
- P/E Ratio
- NMRA N/A
- INFU $38.71
- Revenue Growth
- NMRA N/A
- INFU 7.98
- 52 Week Low
- NMRA $0.61
- INFU $4.61
- 52 Week High
- NMRA $17.19
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- NMRA 45.93
- INFU 54.46
- Support Level
- NMRA $0.66
- INFU $5.08
- Resistance Level
- NMRA $0.73
- INFU $5.83
- Average True Range (ATR)
- NMRA 0.06
- INFU 0.28
- MACD
- NMRA 0.01
- INFU -0.01
- Stochastic Oscillator
- NMRA 59.70
- INFU 53.45
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.